Abstract
A series of novel hexacyclic tetracycline analogues ("hexacyclines") was designed, synthesized, and evaluated for antibacterial activity against a wide range of clinically important bacteria isolates, including multidrug-resistant, Gram-negative pathogens. Valuable structure-activity relationships were identified, and several hexacyclines displayed potent, broad spectrum antibacterial activity, including promising anti-Pseudomonas aeruginosa activity in vitro and in vivo.
MeSH terms
-
Animals
-
Anti-Bacterial Agents / chemical synthesis*
-
Anti-Bacterial Agents / pharmacology*
-
Bacteria / drug effects*
-
Drug Design*
-
Female
-
Humans
-
Mice
-
Mice, Inbred BALB C
-
Microbial Sensitivity Tests
-
Models, Molecular
-
Molecular Structure
-
Pseudomonas Infections / drug therapy
-
Pseudomonas Infections / microbiology
-
Pseudomonas aeruginosa / drug effects
-
Pseudomonas aeruginosa / isolation & purification
-
Structure-Activity Relationship
-
Tetracyclines / pharmacology*
-
Thigh / microbiology
Substances
-
Anti-Bacterial Agents
-
Tetracyclines